Development
IperionX Limited
IPX
$38.29
-$0.33-0.85%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | -3.37% | -3.37% | -49.20% | -49.20% | -34.21% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 16.62% | 16.62% | -19.60% | -19.60% | -18.87% |
Operating Income | -16.62% | -16.62% | 19.60% | 19.60% | 18.87% |
Income Before Tax | -19.89% | -19.89% | 20.70% | 20.70% | 17.12% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -19.89% | -19.89% | 20.70% | 20.70% | 17.12% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -19.89% | -19.89% | 20.70% | 20.70% | 17.12% |
EBIT | -16.62% | -16.62% | 19.60% | 19.60% | 18.87% |
EBITDA | -15.83% | -15.83% | 20.28% | 19.75% | 19.02% |
EPS Basic | 16.67% | 16.67% | 42.61% | 42.61% | 25.00% |
Normalized Basic EPS | 16.58% | 16.58% | 42.80% | 42.80% | 25.20% |
EPS Diluted | 16.67% | 16.67% | 42.75% | 42.75% | 25.00% |
Normalized Diluted EPS | 16.58% | 16.58% | 42.80% | 42.80% | 25.20% |
Average Basic Shares Outstanding | 43.86% | 43.86% | 38.61% | 38.61% | 10.51% |
Average Diluted Shares Outstanding | 43.86% | 43.86% | 38.61% | 38.61% | 10.51% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |